Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Lookingforclueson Jun 24, 2021 3:21pm
205 Views
Post# 33445262

Brief synopsis of GUD etc

Brief synopsis of GUD etcAs you can see GUD bought Exelon from Novartis, who were 'STRUGGLING' and unable to get it moving into a profit.
Please read Novartis struggles to restore sales of Exelon.
If you read what I have written you will see that there seems to be a problem with Exelon.

Knight Theraputics was founded in March 2014...7 years ago at a price of approx $5.00.
Still in the $5.00 range after many failed attempts to make this Company 'work'.
They have lost talented people and have bought back many $Millions of shares.

I was once invested in it, and listened to MugMod/Mugmods/Mr Mugsy and several other advocates, whose presentations were VERY similar.   I sold out several years ago and invested in a real company, where my investment is over 3X
Yes I, and many others lost money on it after the above named convinced us that it was a 2nd Paladin......
I would say to the present readers only one thing......Caveat Emptor.

Thank you.


<< Previous
Bullboard Posts
Next >>